Boost Fund

Boost Venture Fund operates as an early-stage venture capital firm, specializing in healthtech across ophthalmology, cardiology, neuro, and aesthetics. The fund prioritizes execution, deploying capital through commercialization roadmaps. This strategy de-risks investments by providing portfolio companies with core deliverables for intellectual property, clinical development, regulatory navigation, and market entry.

Launched by Octane, Boost Venture Fund is the organization's latest investment vehicle, leveraging its strong track record of scaling startups and facilitating exits. The fund emerged from the insight that early-stage success demands a structured pathway beyond simple capital. It utilizes Octane’s extensive network to strategically vet investments, accelerating growth within its focused healthtech sectors.

Boost Venture Fund primarily supports early-stage healthtech companies, offering both capital and strategic guidance. Its limited partners, mainly physicians, actively serve as advisors and mentors, enriching the fund's ecosystem. The fund’s vision focuses on fostering innovation and economic growth by strategically preparing portfolio companies for successful outcomes and advancing the broader health technology landscape.